RNA Outsourcing Solutions

1. Comprehensive Solutions For Your Vaccine Platforms

   Vaccine production, from process development to full-scale GMP-manufacturing, must be efficient, safe, and cost-effective. Learn how our global capabilities can help you achieve these goals for all your modalities/platforms.

2. NanoImprove The Performance Of Your Biologic Formulation 11/20/2025

   Unlock superior performance for peptides and proteins using nanotechnology. Achieve high drug loads for subcutaneous delivery and stable, aerodynamic dry powders for deep-lung inhalation.

3. Expanding Cell & Gene Therapy Global Supply Chain Offerings 7/26/2023

   As cell and gene therapies continue to transform modern medicine, Cryoport Systems evolves its products and solutions to meet the needs of the industry and the patients it serves.

4. GMP mRNA And LNP-mRNA Manufacturing 5/13/2024

   Easily scale your GMP mRNA projects

5. Advancing Genomic Medicines From Discovery To Commericalization 5/6/2026

   Integrated genomic medicine reduces risk and timelines, improving consistency across modalities from research through clinical and commercial stages.

6. Plasmid DNA Production 6/23/2022

   Integrated manufacturing supporting cell and gene therapies.

   The critical genetic foundation for advanced therapies

   Plasmid DNA is a critical raw material for advanced therapies and mRNA synthesis, supporting their transfection to enable rapid advancement of the therapeutic product. Center for Breakthrough Medicines (CBM) offers capacity dedicated to the development and manufacture of high quality plasmid DNA and other nucleic acids.

7. Cell & Gene Therapy Clinical Development Testing 4/23/2026

   By combining scientific depth with operational scale, we help sponsors make confident, data-driven decisions, reduce development risk, and accelerate the path from discovery to clinical impact.

8. Groundbreaking Cryogenic Freezer Technology 3/7/2023

   Examine the benefits of a new cryogenic storage tank and how this innovative technology will mitigate risk in the cell and gene therapy supply chain.

9. Biologics Development And Manufacturing 6/17/2026

   By combining robust development expertise with scalable GMP manufacturing and comprehensive analytical support, we provide a seamless pathway from process characterization and clinical supply production to long-term commercial success.

10. Simplify Your mRNA Workflow From The Start 4/24/2026

    Cell‑free DNA simplifies mRNA production by removing bacterial risk, stabilizing polyA tails, and eliminating extra steps — delivering higher yields and cleaner workflows.